HUTCHMED (China) Limited
HCM.L · LSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | £139 | £139 | £162 | £162 |
| % Growth | 0% | -14.4% | 0% | – |
| Cost of Goods Sold | £84 | £84 | £190 | £190 |
| Gross Profit | £55 | £55 | -£28 | -£28 |
| % Margin | 39.7% | 39.7% | -17.4% | -17.4% |
| R&D Expenses | £36 | £36 | £59 | £59 |
| G&A Expenses | £14 | £14 | £32 | £32 |
| SG&A Expenses | £21 | £21 | £28 | £28 |
| Sales & Mktg Exp. | £7 | £7 | £24 | £24 |
| Other Operating Expenses | £0 | £0 | -£107 | -£107 |
| Operating Expenses | £57 | £57 | -£20 | -£20 |
| Operating Income | -£2 | -£2 | -£8 | -£8 |
| % Margin | -1.3% | -1.3% | -5% | -5% |
| Other Income/Exp. Net | £261 | £261 | £16 | £16 |
| Pre-Tax Income | £259 | £259 | £8 | £8 |
| Tax Expense | £32 | £32 | £2 | £2 |
| Net Income | £227 | £227 | £6 | £6 |
| % Margin | 163.8% | 163.8% | 3.7% | 3.7% |
| EPS | 0.27 | 0.27 | 0.007 | 0.007 |
| % Growth | 0% | 3,757.1% | 0% | – |
| EPS Diluted | 0.26 | 0.26 | 0.005 | 0.005 |
| Weighted Avg Shares Out | 875 | 875 | 1,192 | 1,192 |
| Weighted Avg Shares Out Dil | 873 | 873 | 873 | 873 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £19 | £19 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £3 | £3 | £3 | £3 |
| EBITDA | £1 | £1 | -£5 | -£5 |
| % Margin | 0.9% | 0.9% | -3.1% | -3.1% |